Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...

Is it cost-effective? This question is increasingly asked about health interventions as we attempt to achieve the maximum benefit from limited health care resources. As a result, cost–effectiveness ...

Our study was designed as a cost-utility investigation aimed at determining the cost per QALY gained in adult patients with refractory epilepsy given adjunctive therapy with topiramate. Data of ...

In healthcare economics a form of cost-effectiveness analysis in which the results are expressed in terms of cost per quality adjusted life year (QALY) gained. In health economics the purpose of CUA ...

Phase I Trial Using a Time-to-Event Continual Reassessment Strategy for Dose Escalation of Cisplatin Combined With Gemcitabine and Radiation Therapy in Pancreatic Cancer We used a Markov model to ...

Objective To investigate the cost-effectiveness of exercise therapy in the treatment of patients with non-specific neck pain and low back pain. Design Systematic review of economic evaluations. Data ...

MENLO PARK, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing ...

Cost-Utility Analysis published in the Expert Review of Pharmacoeconomics and Outcomes Research MENLO PARK, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight ...